A rare homozygous <i>CAPN3</i> variant with distinct clinical features in unrelated families of Iraqi Jewish descent
<i>CAPN3</i> encodes a calcium-activated skeletal muscle-specific protease. Pathogenic variants in <i>CAPN3</i> are associated with autosomal recessive and dominant limb-girdle muscular dystrophy. We report on three children and one adult from four unrelated Iraqi Jewish families, who harbor the same homozygous variant in <i>CAPN3</i>, p.Gln123Lys. Patients shared recognizable features of toe-walking and elevated creatine phosphokinase since childhood. The variant affects a conserved protein domain common to the calpain super family and likely represents a founder mutation in individuals of Iraqi Jewish ancestry. Our findings have potential implications on screening in relevant populations, allowing for more prompt diagnoses and future therapies.
Authors
- Nurit Assia Batzir (ORCID: https://orcid.org/0000-0001-8018-226X)
- Gabriel Lidzbarsky (ORCID: https://orcid.org/0000-0002-1484-6176)
- Osnat Konen (ORCID: https://orcid.org/0000-0002-6265-6705)
- Yoram Nevo
- Lina Basel‐Vanagaite (ORCID: https://orcid.org/0000-0002-9076-8157)
- Alla Kuzminsky
- Yuval Yaron (ORCID: https://orcid.org/0000-0001-8622-7668)
- Lily Bazak (ORCID: https://orcid.org/0000-0003-3632-2151)
- Naama Orenstein
- Sharon Aharoni (ORCID: https://orcid.org/0000-0001-7255-6276)
Institutions
- Rafael Advanced Defense Systems (Israel) (IL)
- Tel Aviv University (IL)
- Tel Aviv Sourasky Medical Center (IL)
- Rabin Medical Center (IL)
- Schneider Children's Medical Center (IL)
Publication Details
- Journal
- Journal of Neuromuscular Diseases
- Published
- 2024-12-20
- DOI
- https://doi.org/10.1177/22143602241301658
- Primary Topic
- Calpain Protease Function and Regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00